tenk.fyi

Immix Biopharma, Inc.

IMMXNasdaq· Pharmaceutical Preparations

Price History

Revenue

-

Net Income

-$21.6M

40.1% YoY

EPS

$-0.76

14.6% YoY

Cash

$17.7M

1.0% YoY

FY 2024 · As of 2024-12-31

Pro

10-K Year-over-Year Diff

AI-powered analysis of what changed between the last two annual reports — new risks, removed language, strategy shifts.

Upgrade to Pro